The pharmaceutical firm's net revenue went down 3.4 per cent to Rs 5,739 crore against Rs 5,941 crore in the corresponding period the previous year.
Net Ebitda of the company went down 33 per cent to Rs 790 crore against Rs 1,186 crore in the year-ago period.
\
\
\
\
